<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0185866.ref018">
 <label>18</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Vallet</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Viron</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Henquell</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Le Guillou-Guillemette</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Lagathu</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Abravanel</surname>
   <given-names>F</given-names>
  </name>
  <etal>et al</etal>
  <article-title>NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1–5</article-title>. 
  <source>Antivir Ther</source>. 
  <year>2011</year>; 
  <volume>16</volume>: 
  <fpage>1093</fpage>–
  <lpage>102</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3851/IMP1900" xmlns:xlink="http://www.w3.org/1999/xlink">10.3851/IMP1900</ext-link>
  </comment>
  <?supplied-pmid 22024525?>
  <pub-id pub-id-type="pmid">22024525</pub-id>
 </mixed-citation>
</ref>
